115 related articles for article (PubMed ID: 1898643)
1. Flecainide acetate for long-term prevention of paroxysmal supraventricular tachyarrhythmias.
Benditt DG; Dunnigan A; Buetikofer J; Milstein S
Circulation; 1991 Jan; 83(1):345-9. PubMed ID: 1898643
[No Abstract] [Full Text] [Related]
2. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
Henthorn RW; Waldo AL; Anderson JL; Gilbert EM; Alpert BL; Bhandari AK; Hawkinson RW; Pritchett EL
Circulation; 1991 Jan; 83(1):119-25. PubMed ID: 1898640
[TBL] [Abstract][Full Text] [Related]
3. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.
Anderson JL; Platt ML; Guarnieri T; Fox TL; Maser MJ; Pritchett EL
Am J Cardiol; 1994 Sep; 74(6):578-84. PubMed ID: 8074041
[TBL] [Abstract][Full Text] [Related]
4. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M; Cullen MT; Casadei G
Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
[TBL] [Abstract][Full Text] [Related]
5. Long term evaluation of flecainide acetate in supraventricular tachyarrhythmias.
Mary-Rabine L; Telerman M
Acta Cardiol; 1988; 43(1):37-48. PubMed ID: 3132008
[TBL] [Abstract][Full Text] [Related]
6. Flecainide for supraventricular tachyarrhythmias.
Med Lett Drugs Ther; 1992 Jul; 34(875):71-2. PubMed ID: 1630411
[No Abstract] [Full Text] [Related]
7. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
Hoff PI; Tronstad A; Oie B; Ohm OJ
Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798
[TBL] [Abstract][Full Text] [Related]
8. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators.
Anderson JL
Am J Cardiol; 1992 Aug; 70(5):11A-17A; discussion 17A-18A. PubMed ID: 1509993
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
[TBL] [Abstract][Full Text] [Related]
11. Use of flecainide acetate in the treatment of supraventricular tachyarrhythmias.
Marwick TH; Woodhouse SP
Am J Cardiol; 1988 Jul; 62(1):171. PubMed ID: 3132846
[No Abstract] [Full Text] [Related]
12. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
[TBL] [Abstract][Full Text] [Related]
14. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.
Furlanello F; Guarnerio M; Inama G; Vergara G; Del Greco M; Bertoldi A; Dallago M
Am J Cardiol; 1992 Aug; 70(5):19A-25A. PubMed ID: 1509994
[TBL] [Abstract][Full Text] [Related]
17. [Selection of protection regimen of dual-chamber cardiac pacing against paroxysmal supraventricular tachycardia].
Cherkasov VA; Protopopov VV; Molodykh SV
Kardiologiia; 2003; 43(4):43-51. PubMed ID: 12891250
[TBL] [Abstract][Full Text] [Related]
18. [Use of flecainide in the preventive treatment of tachycardia crisis of Wolff-Parkinson-White syndrome in 4 newborn infants].
Lupoglazoff JM; Jacqz-Aigrain E; Denjoy I; Casasoprana A
Arch Fr Pediatr; 1991 Nov; 48(9):627-9. PubMed ID: 1763931
[TBL] [Abstract][Full Text] [Related]
19. Long term use of flecainide in patients with supraventricular tachycardia.
Neuss H
Drugs; 1985; 29 Suppl 4():21-5. PubMed ID: 4006776
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
Chachua T; Abuladze G; Nebieridze M
Georgian Med News; 2010 Jun; (183):18-21. PubMed ID: 20622270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
